Trial Profile
Randomised, double-blind, placebo-controlled, cross-over study to examine the effects of tiotropium on lung hyperinflation, respiratory mechanics and dyspnea during exercise in patients with COPD [chronic obstructive pulmonary disease]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Sep 2007
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics; Therapeutic Use
- Sponsors Boehringer Ingelheim
- 01 Sep 2007 Results have been published
- 28 Mar 2007 New trial record.